MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.rmed.2025.108057

Медицинская библиотека · Respiratory medicine · 2025

Outcomes of high-flow versus conventional oxygen therapy in adult medical and post-surgical oncology patients: A systematic review and meta-analysis.

Heybati Shayan, Malone Sarah, Heybati Kiyan, Deng Jiawen, Zhou Fangwen, Roy Angelique, Patel Shubh, Muscedere John, Heffernan Paul

СтатьяСистематический обзорМетаанализСравнительное исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

While the outcomes of patients with cancer have improved, the prognosis for those requiring invasive mechanical ventilation (IMV) remains poor. High-flow nasal cannula (HFNC) can be used as a management strategy to avoid IMV.

OBJECTIVES

To determine the efficacy and safety of HFNC compared to other non-invasive oxygenation techniques among patients with cancer.

METHODS

This systematic review was prospectively registered and followed PRISMA guidelines. Literature searches were conducted from inception to May 17th, 2023, across MEDLINE, EMBASE, CINAHL, CENTRAL, and Web of Science. We included observational studies and randomized controlled trials enrolling adults (≥18 years of age) with an underlying cancer diagnosis that compared HFNC to at least one other form of non-invasive oxygenation.

RESULTS

Seven (n = 501) medical and 4 (n = 379) post-esophagectomy studies were included. There were no significant differences in all-cause mortality (n = 573; RR 0.81; 95 % CI: 0.48 to 1.36; I2 = 9 %) or invasive mechanical ventilation (IMV) (n = 540; RR 0.89; 95 % CI: 0.62 to 1.28; I2 = 47 %). HFNC was associated with lower nose/mouth dryness overall (n = 398; RR 0.37; 95 % CI: 0.24 to 0.58; I2 = 20 %). Across post-esophagectomy studies, HFNC was associated with shorter hospital length of stay (LOS) (n = 309; MD -88.73 h; 95 % CI: 108.94 to -68.52 h; I2 = 0 %). Among medical studies, one study reported a shorter hospital LOS.

CONCLUSIONS

Among hospitalized patients with cancer, there were no significant differences in mortality, IMV use, ICU LOS, or skin damage. Across both cohorts, HFNC was associated with shorter hospital LOS and lower rates of nose/mouth dryness compared to other non-invasive oxygen techniques.

PROSPERO REGISTRATION: CRD42022303621.

Для цитирования: Heybati Shayan, Malone Sarah, Heybati Kiyan, Deng Jiawen, Zhou Fangwen, Roy Angelique, Patel Shubh, Muscedere John, Heffernan Paul. Outcomes of high-flow versus conventional oxygen therapy in adult medical and post-surgical oncology patients: A systematic review and meta-analysis.. Respiratory medicine. 2025. DOI: 10.1016/j.rmed.2025.108057.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.